SINGAPORE, SG / ACCESS Newswire / April 9, 2026 / Immortal Dragons, the $40 million purpose-driven longevity fund, announced that its portfolio company Frontier Bio has received the Best Paper Award ...

Paul Stankey (left) is a fourth-year PhD student at Harvard School of Engineering and Applied Sciences and the Wyss Institute (both MA, USA), working in Professor Jennifer Lewis’ lab. Jennifer leads a ...

When biomedical researchers need to test their latest ideas, they often turn to engineered human tissue that mimics the responses in our own bodies. It's become an important intermediary step before ...

Researchers at Niigata University have used advanced three-dimensional (3D) imaging to reveal how amyloid β (Aβ) deposits spread along blood vessels in the human brain in cerebral amyloid angiopathy ...

Boston Children's Hospital scientists have unveiled a five-day approach to generate functional vascular organoids capable of supporting blood flow and in vivo engraftment. Subscribe to our newsletter ...

Humacyte, a bioengineering company, went public through a SPAC merger in 2015, with a market value of $1.1 billion. The company has received FDA's RMAT designation for three indications, including ...

Assembloids: A Versatile Platform for Human Tissue Modeling. This schematic illustrates the classification of assembloids based on four key assembly strategies—multi-region, multi-lineage, ...

Andrei Georgescu, PhD, CEO of Vivodyne, was hoping to couple his interests in science and engineering when he chose UPenn for his graduate research. His goal was to build on his background in ...

Using postmortem human brain tissue, three-dimensional imaging revealed vascular Aβ deposition patterns and a lower density of parenchymal amyloid plaques surrounding Aβ-positive vessels. Smooth ...